StonvexLoading…
StonvexStonvexStonvexCore line items from PRGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-11-30 | Annual 2024 2024-11-30 | Annual 2023 2023-11-30 | Annual 2022 2022-11-30 |
|---|---|---|---|---|
Revenue | $977.83M | $753.41M | $694.44M | $602.01M |
Operating Income | $153.29M | $124.00M | $110.52M | $132.13M |
Net Income | $73.13M | $68.44M | $70.20M | $95.07M |
EPS (Diluted) | $1.66 | $1.54 | $1.57 | $2.15 |
Total Assets | $2.46B | $2.53B | $1.60B | $1.41B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $94.81M | $118.08M | $126.96M | $256.28M |
Free Cash Flow OCF − CapEx | $229.49M | $206.29M | $168.35M | $186.07M |
Shares Outstanding | 42.34M | 43.36M | 43.80M | 43.26M |